Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore.
Clinical Research Unit, Diabetes Centre, Khoo Teck Puat Hospital, Singapore.
Diabet Med. 2017 Aug;34(8):1145-1153. doi: 10.1111/dme.13358. Epub 2017 May 22.
To gain insight into the presence of islet cell autoimmunity in an ethnic Asian compared with a white European population.
For this cross-sectional study we recruited people with adult-onset diabetes (age of diagnosis 20-60 years), at tertiary referral centres in Germany (n=1020) and Singapore (n=1088). Glutamic acid decarboxylase and islet antigen 2 antibodies were measured according to Islet Autoantibody Standardization Program protocols.
The prevalence of glutamic acid decarboxylase antibody positivity was 13.9% (95% CI 12.1-16.0; P<0.001) in the white European cohort compared with 6.8% (95% CI 5.5-8.4; P<0.001) in the Asian cohort. Glutamic acid decarboxylase antibody positivity was 11.4% (95% CI 7.7-16.6) in Indian, 6.0% (95% CI 3.6-9.9) in Malay and 5.8% (95% CI 4.3-7.7; P<0.001) in Chinese participants. In the white European participants, the prevalence of islet antigen 2 antibody positivity was 7.8% (95% CI 6.4-9.4) compared with 14.8% (95% CI 12.8-17.0; P<0.001) in the Asian cohort as a whole, and among the three ethnicities in the Asian cohort it was 12.4% (95% CI 8.6-17.7) in Indian, 16.8% (95% CI 12.6-22.2) in Malay and 15.7% (95% CI 13.2-18.6) in Chinese participants. Double antibody positivity was seen in 5.7% (95% CI 4.5-7.1) of white European participants compared with 1.6% (95% CI 1.0-2.5; P<0.01) of Asian participants. In the white European cohort, those who were glutamic acid decarboxylase autoantibody-positive had a lower BMI than those who were autoantibody-negative, but this trend was absent in the Asian cohort.
A marked prevalence of islet cell autoimmunity was observed in people with adult-onset diabetes. While glutamic acid decarboxylase antibodies were more frequent in the European cohort, islet antigen 2 antibody positivity was highest in the three ethnic groups in Singapore, suggesting ethnic-specific differences in antibody profiles.
了解亚洲种族与白种欧洲人群中胰岛细胞自身免疫的存在情况。
本横断面研究招募了在德国(n=1020)和新加坡(n=1088)三级转诊中心确诊为成年发病糖尿病(发病年龄 20-60 岁)的人群。根据胰岛自身抗体标准化计划方案检测谷氨酸脱羧酶和胰岛抗原 2 抗体。
白种欧洲队列谷氨酸脱羧酶抗体阳性率为 13.9%(95%CI 12.1-16.0;P<0.001),而亚洲队列为 6.8%(95%CI 5.5-8.4;P<0.001)。谷氨酸脱羧酶抗体阳性率在印度人群中为 11.4%(95%CI 7.7-16.6),在马来人群中为 6.0%(95%CI 3.6-9.9),在华裔人群中为 5.8%(95%CI 4.3-7.7;P<0.001)。在白种欧洲人群中,胰岛抗原 2 抗体阳性率为 7.8%(95%CI 6.4-9.4),而整个亚洲队列为 14.8%(95%CI 12.8-17.0;P<0.001),在亚洲三个种族中,印度人为 12.4%(95%CI 8.6-17.7),马来人为 16.8%(95%CI 12.6-22.2),华裔人为 15.7%(95%CI 13.2-18.6)。白种欧洲人群中双抗体阳性率为 5.7%(95%CI 4.5-7.1),而亚洲人群中为 1.6%(95%CI 1.0-2.5;P<0.01)。在白种欧洲队列中,谷氨酸脱羧酶自身抗体阳性者的 BMI 低于自身抗体阴性者,但在亚洲队列中未观察到这种趋势。
在成年发病糖尿病患者中观察到明显的胰岛细胞自身免疫流行。虽然谷氨酸脱羧酶抗体在欧洲队列中更为常见,但在新加坡的三个种族中,胰岛抗原 2 抗体阳性率最高,提示抗体谱存在种族特异性差异。